| MGX Stock | | | 2.01 0.12 6.35% |
Founder
Jak MD is CoFounder Board of Metagenomi, Common Stock
| Address | 5959 Horton Street, EmeryVille, CA, United States, 94608 |
| Phone | 510 871 4880 |
| Web | https://www.metagenomi.co |
Metagenomi, Common Management Efficiency
The company has Return on Asset of
(0.1392) % which means that on every $100 spent on assets, it lost $0.1392. This is way below average. In the same way, it shows a return on shareholders' equity
(ROE) of
(0.2898) %, meaning that it generated no profit with money invested by stockholders. Metagenomi, Common's management efficiency ratios could be used to measure how well Metagenomi, Common manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Equity is likely to rise to 0.64 in 2024, whereas
Return On Tangible Assets are likely to drop
(0.20) in 2024. At this time, Metagenomi, Common's
Fixed Asset Turnover is fairly stable compared to the past year.
Asset Turnover is likely to rise to 0.13 in 2024, whereas
Total Assets are likely to drop slightly above 337.8
M in 2024.
Metagenomi, Common Stock (MGX) is traded on NASDAQ Exchange in USA. It is located in 5959 Horton Street, EmeryVille, CA, United States, 94608 and employs 236 people. Metagenomi, Common is listed under Biotechnology category by Fama And French industry classification.
Management Performance
Metagenomi, Common Stock Leadership Team
Elected by the shareholders, the Metagenomi, Common's board of directors comprises two types of representatives: Metagenomi, Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Metagenomi,. The board's role is to monitor Metagenomi, Common's management team and ensure that shareholders' interests are well served. Metagenomi, Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Metagenomi, Common's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian Thomas, CEO CoFounder | |
| Jian MBA, COO President | |
| Pamela MBA, Chief Officer | |
| Joseph MD, CoFounder Board | |
| Simon MSc, Chief Relations | |
| Luis Borges, Chief Officer | |
| Matthew JD, Compliance Legal | |
| Christopher Brown, Head Discovery | |
| Jak MD, CoFounder Board | |
| Alan Brooks, Senior Preclinical | |
| Simren LLM, Vice Legal | |
Metagenomi, Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Metagenomi, Common a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Metagenomi, Stock Analysis
When running Metagenomi, Common's price analysis, check to
measure Metagenomi, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Metagenomi, Common is operating at the current time. Most of Metagenomi, Common's value examination focuses on studying past and present price action to
predict the probability of Metagenomi, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Metagenomi, Common's price. Additionally, you may evaluate how the addition of Metagenomi, Common to your portfolios can decrease your overall portfolio volatility.